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Fumonisins are a group of hydrophilic myco-
toxins produced by fungi of the Fusarium
species. Fumonisin B1 (FB1) was the first
fumonisin identiﬁed, and this led to the dis-
covery of several different homologues (1–4).
The Fusarium fungi have been shown to con-
taminate crops (primarily corn or maize)
worldwide (5), and the severity of the infec-
tion depends on environmental conditions
such as drought and heat. Fusarium monili-
forme Sheldon (= F. verticillioides) is consid-
ered the dominant species of Fusarium on
crops that produces FB1, although other
species have been shown to produce FB1 and
the other fumonisins in culture (6–13). The
predominant fumonisin homologues (B1, B2,
B3) differ on the basis of hydroxyls at posi-
tions C5 and C10 (1–3).
The discovery of FB1 was the result of
long-term investigations into the reasons for
regiospecificity in the occurrence of
esophageal cancer in South Africa. Areas in
the Transkei that are only 150 km apart have
esophageal cancer incidences that differ 2- to
3-fold (14,15). Cytologic analysis of
esophageal scrapings from patients in these
areas showed that cytologically abnormal
esophageal mucosal cells were present in
patients from the high-risk area (16).
Furthermore, investigators demonstrated a
higher incidence of F. moniliforme in maize
from households in the high-risk area than in
the low-risk area of the Transkei (16,17).
These ﬁeld investigations led to the isolation
from household corn of several isolates of
F. moniliforme (18–20). Including isolate
F. moniliforme MRC 826 in the diet of BD
IX rats for 22–27 months led to formation of
esophageal hyperplasia, forestomach papillo-
mas and carcinomas, hepatocellular carcino-
mas, and cholangiocarcinomas (21).
FB1 was isolated as the compound present
in cultures of F. moniliforme MRC 826 that
promoted the formation of preneoplastic
altered enzyme foci in the livers of dimethyl-
nitrosamine-initiated rats (22). In a subse-
quent study, including FB1 at 50 mg/kg in
the diet of BD IX rats led to development of
liver tumors (23). Hepatic regenerative nod-
ules, cholangiofibrosis, and cirrhosis devel-
oped in all 10 rats maintained on the FB1 for
20–26 months, whereas only 7 of 10 rats
developed hepatocellular carcinomas (23).
Although this study was limited to a single
dose of FB1 in the diet and included only a
small number of rats, when combined with
the tumor promotion studies (22) it strongly
suggested that FB1 was a rodent carcinogen.
FB1 was nominated for tumorigenesis test-
ing under the auspices of the National
Toxicology Program because of the carcino-
genesis of FB1 and F. verticillioides MRC 826
in rats, the presence of FB1 in maize in areas of
the world with high incidences of esophageal
cancer (5) attributed to the presence of FB1 in
food destined for human consumption
(maize), and because of the lack of fundamental
dose–response data available to assist with
setting regulatory levels.
Materials and Methods
Study Material and Feed
FB1 was produced by aqueous cultures of F.
proliferatum on corn. The FB1 was extracted
from the autoclaved material using methanol
and purified as the ammonium salt using
high-performance liquid chromatography
(HPLC). The purity of the FB1 was estab-
lished as > 96% using 1H and 13C nuclear
magnetic resonance spectroscopy, mass spec-
trometry, and HPLC with evaporative light
scattering detection (24).
Autoclaved-powdered NIH-31 rodent
feed (Purina Corp., St. Louis, MO) was the
test diet in the study, and FB1 was added as
a water-based component using a Patterson-
Kelley V-blender (Patterson-Kelley Co., East
Stroudsburg, PA). The FB1 content of
the control diet was below 0.06 parts per
million (ppm).
Animals and Housing
Female and male Fischer 344/N/Nctr BR rats
and B6C3F1/Nctr BR mice were obtained
from the National Center for Toxicological
Research (NCTR) breeding colony at 4 weeks
postpartum. The rats and mice were allocated
to the study dose groups in a random manner
that controlled for weight bias and minimized
occurrence of littermates in the same dose
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group. The rats were housed two per cage
and the mice four per cage in polycarbonate
cages with autoclaved hardwood chip bed-
ding. Cagemates were identiﬁed using an ear-
clip identiﬁcation system. Water was available
ad libitum. The powdered feed was available
ad libitum in custom feeders designed for
powdered feed. The cages and water were
changed twice weekly for the rats and weekly
for the mice.
Study Design
The doses of FB1 for the rats were based on
toxicities detected in 28-day and 90-day sub-
chronic studies (24–26). The doses for the
bioassay were 0, 5, 15, 50, and 100 ppm FB1
for female F344 rats and 0, 5, 15, 50, and
150 ppm FB1 for the male F344 rats. 
The doses of FB1 for the B6C3F1 mice
were based on the response of the mice in 28-
and 90-day subchronic studies (24,25). The
FB1 doses used with the female mice were 0,
5, 15, 50, and 80 ppm FB1, whereas the
doses used in the diets for the male mice were
0, 5, 15, 80, and 150 ppm FB1. 
The study was conducted in accordance
with the guidelines of the National
Toxicology Program (27) and the U.S. Food
and Drug Administration (28). Animals were
allocated 48 for each sex per dose group
except for the groups receiving diets contain-
ing 5 ppm FB1, in which there were 40 rats
of each sex. The mice and rats were accli-
mated to the cage and control powdered feed
until 6 weeks postpartum, when the dosed
feed was added. 
Animals were necropsied after 104 weeks
of consumption of the dosed feed or upon
removal as moribund or dead. The livers and
kidneys from all the animals were examined
microscopically, whereas other tissues were
examined only for animals receiving control
or high-dose diets (24). Pathologic examina-
tions were conducted as described for the
National Toxicology Program (27).
Statistical Analysis
Tests of pairwise comparisons of the neoplas-
tic and non-neoplastic lesions for each
exposed group with the controls was con-
ducted using the Poly-k test (24,29,30). A k-
value of 3 was used in these analyses (30).
The analysis includes a risk–weight adjust-
ment on animals that died before completion
of the study and reports an adjusted rate of
lesion incidence. 
Results
The female F344 rats that consumed diets
containing 100 ppm FB1 had decreased
weights compared to the body weights of the
female F344 rats on the control diets (Figure
1A). No body weight differences were
detected in the female F344 rats that
consumed diets containing 5, 15, and 50
ppm FB1 compared to the female F344 rats
on the control diet (Figure 1A). The daily
mean consumption of diet by the male and
female rats during the course of the study was
indistinguishable from the dietary consump-
tion of other F344/N/Nctr BR rats at this
facility (data not shown) The mean consump-
tion rates of compound in the female rats
between weeks 51 and 104 on the dosed feed
were 0, 0.27, 0.78, 2.57, and 5.24 mg FB1
per kg body weight per day (mg/kg bw/day)
for 0, 5, 15, 50, and 100 ppm diets, respec-
tively. There were no FB1-dependent changes
in the body weights of the male F344 rats
that consumed up to 150 ppm FB1 (Figure
1B). The mean consumption rates of FB1
between weeks 51 and 104 of the study were
0, 0.22, 0.67, 2.24, and 6.60 mg/kg bw/day
for male rats consuming diets containing 0, 5,
15, 50, and 150 ppm FB1. 
There were no dose-related differences in
the survival of the female F344 rats at 104
weeks (Figure 2A). The survival for female
F344 rats on the control diet was 52%,
whereas the survival of female F344 rats con-
suming the 100 ppm FB1 diet was 60%.
Consumption of the FB1 dose used in the
study did not induce toxicity that could be
detected by changes in body weight through-
out the 2-year study.
There were no dose-related differences in
the survival rates of the male F344 rats, with
35% of the male F344 rats on the control
diet and 52% of the male F344 rats consum-
ing diets with 150 ppm FB1 surviving for 2
years (Figure 2B).
Necropsy and microscopic evaluation of
the tissues of the male F344 rat revealed an
increase in renal tubule adenomas and carci-
nomas (Table 1). No tumors were present in
the kidneys of the male F344 rats that con-
sumed diets containing 0, 5, or 15 ppm FB1.
Renal tubule adenomas were present in 2 of
the 48 male F344 rats consuming 50 ppm
FB1, and renal tubule carcinomas were pre-
sent in 7 of the 48 rats on this dose. This
produced an adjusted incidence of 25.7%
for renal adenomas and carcinomas in the
male rats at the 50 ppm FB1 dose. The
development of renal tubule adenomas and
carcinomas was more pronounced in male
F344 rats that consumed 150 ppm FB1
(Table 1), with 5 of the 48 rats developing
adenomas and 10 of the 48 rats developing
carcinomas, for an adjusted incidence of
38.1% of the rats at the 150 ppm FB1 dose
with adenomas or carcinomas. These
increases in adenomas at 150 ppm, carci-
noma at 50 and 150 ppm, and adenoma or
carcinoma at 50 and 150 ppm were signifi-
cant for the control group (Table 1).
Figure 1. Body weights of female (A) and male (B)
F344/N/Nctr BR rats in the 2-year tumor study. The body
weights were measured weekly, and are shown at 4-
week intervals starting at 20 weeks. The following FB1
doses were given to the female F344 rats: control diets
(——), 5 ppm (– – –), 15 ppm (— — —), 50 ppm 
(– • –), and 100 ppm (– • • –). The following FB1 doses
were given to the male F344 rats: control diets (——), 5
ppm (– – –), 15 ppm (— — —), 50 ppm (– • –), and
150 ppm (– • • –). 
Figure 2. Survival of female (A) and male (B)
F344/N/Nctr BR rats in the 2-year tumor study. Survival
rates are expressed as the fraction of rats initially loaded
into the study that survived to the end of the indicated
week. The following FB1 doses were given to the female
F344 rats: control diets (——), 5 ppm (– – –), 15 ppm 
(— — —), 50 ppm (– • –), and 100 ppm (– • • –). The
following FB1 doses were given to the male F344 rats:
control diets (——), 5 ppm (– – –), 15 ppm (— — —),
50 ppm (– • –), and 150 ppm (– • • –).
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Among the female F344 rats, there were
no FB1-dependent changes in the incidence
of tumors. One renal adenoma was detected
in a female F344 rat consuming 50 ppm FB1,
and one renal tubule carcinoma was detected
in a female F344 rat that consumed 100 ppm
FB1; however, from the Poly-k analysis, the
low frequency of these tumors did not indi-
cate a dose-related trend.
The renal tubule adenomas were charac-
terized by a deﬁned focus of expansive tubule
cells. The nuclear and cell volumes were
increased in adenoma cells compared to nor-
mal adjacent cells. The cytoplasm of the ade-
noma cells stained clear to basophilic. A
representative adenoma is shown in Figure 3.
The renal tubule carcinomas were charac-
terized as growths of abnormal and atypical
cells that compressed and invaded neighbor-
ing normal tissue (Figure 4). The cells within
the growing boundary of the carcinoma con-
tained basophilic cytoplasm with typically
increased volume and hyperchromatic nuclei.
Necrosis was evident within the interior of the
larger carcinomas. In many of the carcinomas,
small renal tubule-like structures were evident.
These renal tubule carcinomas metastasized to
the lung and lymphatic tissues.
We detected no differences in the body
weights of the female B6C3F1 mice (Figure
5A) or in the consumption of the diets con-
taining FB1 (data not shown) when compared
to those of mice receiving control diets. The
mean daily consumption of FB1 between
weeks 51 and 104 of the study were 0, 0.65,
1.91, 6.62, and 12.76 mg/kg bw/day for the
groups receiving 0, 5, 15, 50 and 80 ppm
FB1, respectively. Similarly, the body weights
of the male B6C3F1 mice consuming diets
containing FB1 did not differ from the body
weights of the male B6C3F1 mice on control
diets (Figure 5B). The mean daily consump-
tion of FB1 in the male mice receiving 0, 5,
15, 50, and 150 ppm FB1 was 0, 0.53, 1.55,
9.04, and 15.41 mg/kg bw/day, respectively,
between weeks 51 and 104 of the study. The
body weights of the male mice were approxi-
mately 15% less than the body weights of
B6C3F1/Nctr BR mice in other studies con-
ducted at NCTR, whereas the body weights
of the female mice were 30% less than
expected. Analysis of the feed consumption
rates indicated that the mice were consuming
approximately 30% less feed than mice in
other studies at NCTR. The lower consump-
tion of feed apparently was not caused by
palatability, because feed consumption was
reduced in the control groups. Availability of
the feed through the screen feeders was
reduced, although particle size analysis of the
feed did not indicate that the powdered feed
was altered by the addition of FB1. 
Survival of the female B6C3F1 mice con-
suming 80 ppm FB1 decreased compared to
survival of mice consuming control diets or
diets containing 0–50 ppm FB1 (Figure 6A).
This decrease in survival started at approxi-
mately 1 year of age and continued until the
end of the study. Female B6C3F1 mice con-
suming the other FB1 diets had survival rates
indistinguishable from those of female mice
consuming control diets (Figure 6A).
Exposure to FB1 had no effect on survival of
male B6C3F1 mice at any of the doses
(Figure 6B).
Hepatocellular adenomas were present in
11.7% of the female B6C3F1 mice given con-
trol diet for 2 years (Table 2). Hepatocellular
adenomas were present at adjusted rates of
6.5 and 2.1% at 5 and 15 ppm FB1; these
values were not statistically significantly dif-
ferent from the incidence in the control
group. In females consuming 50 and 80 ppm
FB1, the adjusted rates for the incidence of
adenoma increased to 36.3 and 73.7%,
respectively. Hepatocellular carcinomas were
not present in female B6C3F1 mice given 0,
5, or 15 ppm FB1. Hepatocellular carcinomas
were present at adjusted rates of 22.5 and
23% among female B6C3F1 mice that con-
sumed 50 and 80 ppm FB1, respectively
(Table 2). Consumption of FB1 increased the
adjusted rate of incidence of hepatocellular
adenomas and carcinomas from 11.7% of the
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Table 1. Incidences of neoplastic and non-neoplastic lesions in male rat kidneys. 
Number of rats examined
Type of lesion 48 40 48 48 48
Renal tubule epithelial hyperplasia 2 1 4 14a 8a
Renal tubule adenoma 0 0 0 2 5
Adjusted rate (percent)b 0 0 0 5.7 12.9
Signiﬁcanceb –– – p = 0.2293 p = 0.0314
Renal tubule carcinoma 0 0 0 7 10
Adjusted rate (percent) 0 0 0 20.0 25.4
Signiﬁcance – – – p = 0.0059 p = 0.0008
Renal tubule adenoma or carcinoma 0 0 0 9 15
Adjusted rate (percent) 0 0 0 25.7 38.1
Signiﬁcance – – – p = 0.0011 p = 0.0001
aSigniﬁcantly different from control group (p < 0.05) using the Poly-k test described in “Methods.” bThe adjusted incidence rate and
signiﬁcance were determined using the Poly-k test.
Figure 3. Photomicrograph of renal tubule adenoma from a male F344/N/Nctr BR rat
that consumed a diet containing 150 ppm FB1. The adenoma is present in the lower left
side of the photomicrograph as a focus of cells that disrupted normal tubule
organization. 
Figure 4. Photomicrograph of a renal tubule carcinoma from a male F344/N/Nctr BR
rat that consumed a diet containing 150 ppm FB1. The normal kidney is present on the
right side of the photomicrograph where renal tubules are present. The carcinoma (left
side of photomicrograph) contains cells of atypical morphology, although some tubule-
like organization is found within the tumor.
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female B6C3F1 mice on control diets to 6.5,
2.1, 42.7, and 88.3% of mice consuming
diets that contained 5, 15, 50, and 80 ppm
FB1, respectively (Table 2). The increased
rates of adenomas or carcinomas at 50 and 80
ppm FB1 were statistically signiﬁcantly differ-
ent from those of the control group.
The hepatocellular adenomas were charac-
terized by distinct foci of cells that were either
eosinophilic or basophilic and that routinely
compressed the adjacent normal parenchymal
cells (Figure 7). The carcinomas were charac-
terized by poorly differentiated and anaplastic
cells within the liver (Figure 8). 
Among male B6C3F1 mice, exposure to
FB1 did not affect the incidence of neopla-
sia of any type, including in the liver, where
approximately 25% of the mice had hepato-
cellular adenomas or carcinomas (Table 2).
The increase in numbers of hepatocellular
adenomas or carcinomas in female mice was
accompanied by increases in hepatocellular
hypertrophy at 50 and 80 ppm FB1 (Table
2). Although hypertrophy correlated with
tumor incidence in female mice, it was pre-
sent in the livers of male mice at 80 and 150
ppm (Table 2), but there was no increase in
tumor incidence. 
Discussion
These studies show that FB1 is a renal carcino-
gen when included in the diets of male F344
rats. Renal tubule adenomas or carcinomas
were absent in the male F344 rats consuming
control diets and diets containing 5 or 15
ppm FB1 for 2 years (Table 1). Induction of
renal tubule carcinomas was evident at doses
of 50 and 150 ppm FB1 (Table 1), with
adjusted rates of 22.5 and 23.0%, respectively.
This suggests that a no-observed-effect-level
(NOEL) for the induction of renal tumors in
male rats lies between 15 and 50 ppm FB1.
The highest dose of FB1 included in the diets
of the female F344 rats was 100 ppm; this did
not increase tumor incidence. 
In the present study, including FB1 in
doses as high as 150 ppm in the diets of male
F344 rats and as high as 100 ppm in the diet
of female F344 rats over the 2-year feeding
period did not increase mortality compared
to that of rats consuming control diets
(Figure 2). Similarly, the body weights of the
male and female rats consuming diets con-
taining FB1 did not decrease compared to the
body weights of rats on the control diets
(Figure 1). Therefore, we can conclude that
the dietary levels of FB1 that induced tumors
in male F344 rats (15 ppm < NOEL ≤ 50
ppm) were not close to the maximum toler-
ated dose (MTD), as evidenced by an absence
of effect on the growth and survival of the
dosed rats.
In a feeding study using male BD IX rats,
Gelderblom et al. (23) included 50 ppm FB1
in the diet for up to 26 months. The diet
contained 75% sifted white corn, and the
purity of the FB1 was reported as > 90% (23).
The FB1-fed rats developed hepatic regenera-
tive nodules and cholangiofibrosis (synony-
mous with adenoﬁbrosis), whereas rats on the
control diets did not. The liver dysplasia pro-
gressed to hepatic cirrhosis and hepatocellular
carcinomas in 10 of the 15 rats sacrificed
between 18 and 26 months. In an additional
study, FB1 was fed to male BD IX rats at 0, 1,
10, and 25 ppm for 24 months (31). These
levels of FB1 failed to induce the hepatocellu-
lar carcinomas that were induced in the previ-
ous study with 50 ppm FB1. As a result, the
studies with male BD IX rats suggest that a
NOEL exists between 25 and 50 ppm FB1
for the formation of hepatocellular tumors in
male BD IX rats. Renal tumors in male rats
Figure 5. Body weights of female (A) and male (B)
B6C3F1/Nctr BR mice in the 2-year tumor study. The
body weights were measured weekly and are shown at
4-week intervals starting at 20 weeks. The following FB1
doses were given to the female mice: control diets 
(——), 5 ppm (– – –), 15 ppm (— — —), 50 ppm 
(– • –), and 80 ppm (– • • –). The following FB1 doses
were given to the male mice: control diets (——), 5
ppm (– – –), 15 ppm (— — —), 80 ppm (– • –), and
150 ppm (– • • –). 
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Figure 6. Survival of the female (A) and male (B)
B6C3F1/Nctr BR mice in the 2-year tumor study. Survival
rates are expressed as the fraction of mice initially
loaded into the study that survived to the end of the
indicated week. The following FB1 doses were given to
the female mice: control diets (——), 5 ppm (– – –), 15
ppm (— — —), 50 ppm (– • –), and 80 ppm (– • • –).
The following FB1 doses were given to the male mice:
control diets (——), 5 ppm (– – –), 15 ppm (— — —),
80 ppm (– • –), and 150 ppm (– • • –).
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Table 2. Incidences of neoplastic and non-neoplastic lesions in mouse liver.
Number of female mice examined Number of male mice examined
Type of lesion 47 48 48 47 45 47 47 48 48 48
Diffuse hepatocellular hypertrophy 0 0 0 27a 31a 10 9 24a 25a 30a
Hepatocellular adenoma 5 3 1 16 31 9 7 7 6 8
Adjusted rate (percent)b 11.7 6.5 2.1 36.3 73.7
Signiﬁcanceb – p = 0.3314 p = 0.0862 p = 0.0047 p = 0.0001
Hepatocellular carcinoma 0 0 0 10 9 4 3 4 3 2
Adjusted rate (percent) 0 0 0 22.5 23.0
Signiﬁcance – – – p = 0.0007 p = 0.0007
Hepatocellular adenoma or carcinoma 5 3 1 19 39 12 9 9 9 10
Adjusted rate (percent) 11.7 6.5 2.1 42.7 88.3
Signiﬁcanceb – p = 0.3314 p = 0.0862 p = 0.0005 p = 0.0001
aSigniﬁcantly different from control group (p < 0.01) using the Poly-k test described in “Methods.” bThe adjusted incidence rate and signiﬁcance were determined using the Poly-k test.
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can be induced by compounds that bind to
α2µ-globulin (32,33). The morphology of the
tumors was not consistent with this type of
mechanism. The reasons for the different
organospecificities in tumor formation (i.e.,
livers in the male BD IX rats and kidneys in
the male F344 rats) remain to be elucidated
and warrant additional studies.
The current study is the first to examine
the carcinogenicity of FB1 in mice. Our
results show that FB1 was hepatocarcinogenic
in the female B6C3F1 mice at doses of 50
and 80 ppm, with carcinoma formation in
22.5 and 23% of the mice, respectively
(Table 2). There was an increased incidence
of hepatocellular adenomas in the mice fed
50 and 80 ppm FB1 (Table 2). These results
suggest that the NOEL for adenoma or carci-
noma in the female B6C3F1 mouse is
between 15 and 50 ppm. Failure to increase
the incidence of hepatocellular adenomas and
carcinomas in male B6C3F1 mice and the
lack of an increase in tumors in any other
sites in response to the consumption of FB1-
containing diets suggests a NOEL for tumor
formation in male B6C3F1 mice > 150 ppm.
Little information is available on the
MTD of FB1 in mice to allow comparison of
the FB1 doses required for tumor induction
versus MTD. In a 90-day feeding study with
B6C3F1 mice, Voss et al. (25) demonstrated
that 81 ppm FB1 in the diet was not toxic to
male or female B6C3F1 mice. In male
B6C3F1 mice fed FB1 for 28 days, decreased
body weights were detected in the group that
consumed 484 ppm FB1 but not in the group
fed 234 ppm FB1 (24). The body weights of
female B6C3F1 mice that consumed up to
484 ppm FB1 for 28 days were not affected
(24). Additionally, there were no deaths
among the male or female B6C3F1 mice con-
suming FB1 for 28 days. The body weights
and survival rates of the male B6C3F1 mice
in our 2-year study were not affected by the
FB1 (Figures 5 and 6), suggesting that the
MTD for FB1 in a chronic study is > 150
ppm. Although the body weights of the
female mice were unaffected by doses of FB1
as high as 80 ppm, their survival rates
decreased beginning after approximately 1
year of consuming diets containg FB1 (Figure
6). The cause of death in the mice consuming
80 ppm FB1 was primary liver cancer (data
not shown). Therefore, the MTD for FB1 in
female B6C3F1 mice seems to be between 50
and 80 ppm FB1 because of the appearance of
hepatocarcinogenicity at 80 ppm.
The body weights of the male and female
B6C3F1 mice in the 2-year study were low
when compared to the historical body
weights of B6C3F1 mice at NCTR. This
apparently was caused by an inadvertent
restriction of feed in the feeders used in this
study. With a commercial blender, the FB1
was added as an aqueous solution to predried
powdered NIH-31 rodent feed. Particle
analysis of the feed did not demonstrate any
difference in the particle size before or after
application of the FB1 (data not shown), but
the free flow of the powdered feed in the
mouse feeders apparently was restricted,
which meant that the mice consumed only
about 70% of the amount of feed expected
for an ad libitum study. This explains a
reduction in body weight of approximately
15% for the male B6C3F1 mice and approxi-
mately 20% for the female mice at 52 weeks
in this study, compared to ad libitum studies
with other B6C3F1/Nctr BR mice at NCTR.
The effects of reduced body weight through
feed restriction were increased longevity and
reduced incidence of spontaneous tumor for-
mation (34). Given the body weight of the
male mice at 52 weeks, a liver tumor inci-
dence of 20% would have been expected
(35). The liver tumor rate in the control
group of male B6C3F1 mice in this study was
26%; therefore, it appears that the inadver-
tent feed restriction resulted in the predicted
liver tumor rate among the male mice. In
another study (36), dietary restriction of
female B6C3F1 mice to 60% of ad libitum
reduced liver tumors from 55 to 12% of the
mice. The adjusted liver tumor rate in our
study was 11.7% for the female B6C3F1 mice
consuming control diets. Therefore, it
appears that the feed restriction in our study
resulted in a decrease in liver tumor rates in
the female B6C3F1 mice similar to those
previously reported (36). 
F. moniliforme MRC 826 culture material
was isolated from an area of South Africa that
has a high incidence of esophageal cancer
(18–20). Including this fungal isolate at 0.5%
(wt/wt) in the diet of BD IX rats led to the
development of esophageal hyperplasia and
the development of forestomach and liver
tumors (21). Further studies with the MRC
826 fungal isolate led to the discovery of FB1
as the compound responsible for the induc-
tion of preneoplastic foci in initiated rats (22)
and eventually to hepatic tumor formation in
BD IX rats (23). The purification of FB1
from F. moniliforme MRC 826 has led
researchers to conclude that FB1 is a potential
human esophageal carcinogen. In this study
we were unable to detect any hyperplasia or
tumors in the esophageal tissue of rats or
mice treated for 2 years with FB1. Although
transient increases in esophageal epithelium
labeling index have been reported following
gavage administration of FB1 to rats (37),
other reports have indicated a lack of effect of
FB1 consumption on rat esophageal epithelial
tissue (22–26). 
Esophageal tumors have been induced by
many compounds in rat feeding studies. Most
of these compounds are N-nitrosamines (38),
which are structurally dissimilar from the
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Figure 7. Photomicrograph of a hepatocellular adenoma in a B6C3F1/Nctr BR mouse
that consumed a diet containing 80 ppm FB1. The adenoma is present in the upper cen-
ter of the photomicrograph as a focus of basophilic cells of altered morphology.
Figure 8. Photomicrograph of a hepatocellular carcinoma in a female B6C3F1/Nctr BR
mouse that consumed a diet containing 80 ppm FB1. Some normal hepatic tissue is
shown at the right side of the photomicrograph; the carcinoma is present in the left
center of the photomicrograph.
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fumonisins. Whereas N-nitrosamines are
DNA alkylators, FB1 is a nongenotoxic com-
pound. We have reported that the incubation
of methanolic extracts of Fusarium cultures
with DNA in the presence of rat liver S9 pro-
teins results in the formation of DNA adducts
(39). The chromatographic characteristics of
these unidentiﬁed DNA adducts suggest they
are hydrophobic (39). Therefore, the possibil-
ity exists that compounds present in Fusarium
fungi might alkylate DNA and participate in
the induction of Fusarium-induced rodent
esophageal dysplasia and forestomach tumors.
Further research is required to establish
whether FB1 has a role in the development of
esophageal cancer in humans.
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